Skip to content
healthcare.dev
Get a free key

Adzenys XR-ODT

NDC 70165-015, Amphetamine, tablet, orally disintegrating, from Neos Therapeutics Brands, LLC.

Product NDC
70165-015
Status
Listed
Labeler
Neos Therapeutics Brands, LLC
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA204326
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70165-015 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMPHETAMINE9.4 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
70165-015-307016500153030 BLISTER PACK in 1 CARTON (70165-015-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
70165-015-317016500153130 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (70165-015-31)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c1179269-00b5-48ea-972d-31e614e99b7e

  • NADAC price for package 70165001530

    GET /v1/drugs/nadac/70165001530

Use it

Look up 70165-015 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70165-015 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70165-015. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.